NEW YORK, NY / ACCESS Newswire / July 29, 2025 / Europe is reaching a pivotal moment in its industrial transformation. And ...

That earnings report, unveiled well before market open that day, revealed that GeneDx booked nearly $103 million in revenue. That was 49% higher year over year and was helped greatly by a 69% ...

Investors were clearly impressed by the company's second-quarter beats, especially the one on the bottom line.

The latest figures from the Financial Industry Regulatory Authority (FINRA) show that margin debt in U.S. stocks has crossed ...

In a recent appearance on CNBC’s Squawk on the Street, Jim Cramer discussed America’s latest trade deal with the European ...

The agreement between the EU and U.S. President Donald Trump calls for 15% tariffs on most EU exports to the U.S.

Novo, which became Europe’s most valuable listed company following the launch of Wegovy in 2021, is now facing a reckoning as ...

Broadcom (AVGO) leads the ASIC market, supplying custom chips for high-performance computing. U.S. policy shifts and AI demand provide tailwinds for peers AMD and Nvidia.

Trump’s tariffs and trade deals continue to affect global markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.

Stock markets were mixed on Tuesday as investors started turning their attention from trade deals to a slew of company results falling this week.

Telix Pharmaceuticals' strong sales, diverse pipeline, and theranostics promise support a Buy rating, despite SEC concerns.

The 15 percent tariff rate agreed under the new deal could significantly impact pharma firms reliant on European imports.